Found: 14
Select item for more details and to access through your institution.
The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 1, p. 17, doi. 10.1007/s13555-017-0211-4
- By:
- Publication type:
- Article
Prospective demographic study of cosmetic surgery patients.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Skin care for men and its marketing.
- Published in:
- Dermatologic Therapy, 2007, v. 20, n. 6, p. 452, doi. 10.1111/j.1529-8019.2007.00161.x
- By:
- Publication type:
- Article
Safety and Efficacy of Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in the Treatment of Extensive Scalp Psoriasis in Adolescents Ages 12 to 17 Years.
- Published in:
- Pediatric Dermatology, 2015, v. 32, n. 1, p. 28, doi. 10.1111/pde.12429
- By:
- Publication type:
- Article
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa.
- Published in:
- Annals of Internal Medicine, 2012, v. 157, n. 12, p. 846, doi. 10.7326/0003-4819-157-12-201212180-00004
- By:
- Publication type:
- Article
Corrigendum to: The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Corrigendum to: The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
- Published in:
- Aesthetic Surgery Journal, 2018, v. 38, n. 9, p. 998, doi. 10.1093/asj/sjy008
- By:
- Publication type:
- Article
Efficacy and Safety of ATX-101 by Treatment Session: Pooled Analysis of Data From the Phase 3 REFINE Trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New Uses of AbobotulinumtoxinA in Aesthetics.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 856, doi. 10.1001/jamadermatol.2024.2131
- By:
- Publication type:
- Article